Skip to main content

BSAVA Congress and Expo 26

Manchester, 19-21 March 2026

News

04 Mar 2025

Antech Diagnostics Introduces KeyScreen™ with Angio

Antech Diagnostics Stand: B28
Antech
Antech Diagnostics Introduces KeyScreen™ with Angio
– Antech Diagnostics is excited to announce the enhanced KeyScreen™ with Angio PCR Panel, a ground-breaking addition to their diagnostic offerings.

This innovative technology combines the precision of KeyScreen™ GI Parasite PCR with Angio detection, setting a new standard in veterinary diagnostics.

Key Highlights:

  • Enhanced Diagnostic Accuracy: KeyScreen™ with Lungworm provides unparalleled detection of gastrointestinal parasites, ensuring more accurate and comprehensive results.
  • Improved Patient Care: With faster and more precise diagnostics, veterinarians can offer better treatment plans and improve overall patient outcomes.
  • One Health: Anthelmintic Resistance stewardship considerations 

Revolutionising GI Parasite Screening:

Screening for parasites hasn’t changed much in decades. While O&P (ova and parasites) testing has its strengths, it also has significant weaknesses, relying heavily on visual identification. ELISA testing has known inherent limitations, and there’s no guarantee that parasites (or their eggs) will be present even in an adequately sized sample. Recent efforts to evolve parasite diagnostics still prove time-consuming and suffer from inaccuracies, sample limitations, and narrowly focused tests.

KeyScreen™ has forever changed GI parasite testing:

  • Comprehensive Screening: KeyScreen™ GI Parasite PCR helps find more GI parasites so you can treat your patients with precision, speed, and confidence.
  • Broad Detection: Screen for Ancylostoma spp. (if positive evaluated for benzimidazole resistance by PCR), Uncinaria stenocephala, Toxocara/Toxascaris spp. (if Toxocara spp. positive further speciated into T. canis, T. cati, T. leonina), Baylisascaris procyonis, Trichuris vulpis, Dipylidium caninum, Echinococcus granulosus, Echinococcus multilocularis, Taenia spp., Giardia duodenalis, Cystoisospora spp., Eimeria spp., Cryptosporidium  canis, Cryptosporidium felis, Toxoplasma gondii (feline specific), Neospora caninum, Tritrichomonas blagburni (feline specific), Lungworm (Angiostrongylus vasorum & A. chabaudi), Aelurostrongylus abstrusus, Oslerus/Filaroides spp. (Oslerus osleri / hirthi & O. rostratus), Crenosoma vulpis & Troglostrongylus brevior).
  • Increased Detection Rate: Detect 2x more infections compared to in-clinic faecal flotations (O&P).
  • Resistance Detection: Detect benzimidazole resistance in hookworms.
  • Zoonotic Potential: Determine the zoonotic potential of Giardia.

Priced to support you, your clinic, your clients’ and their pets:

The existing evidence- and expert-based guidelines (CAPC/ CPEP/ESCCAP) support prevention testing, monitoring, and therapy for puppies, kittens, and adult animals.

Parasite Prevalence Statistics:

According to recent data, the prevalence of gastrointestinal parasites in pets remains a significant concern. For example, the Companion Animal Parasite Council (CAPC) reports that the risk of exposure to vector-borne pathogens, including those causing Heartworm and Lungworm disease, Lyme disease, and anaplasmosis, continues to increase.

"At Antech, we are committed to advancing veterinary medicine through innovative diagnostic solutions. KeyScreen™ with Angio detection represents a significant leap forward in our ability to provide accurate and timely diagnoses, ultimately enhancing the care we can offer to our clients and their  patients,"

Rachel Pittaway, Director of Lab Operations at Antech Diagnostics UK

For more information, please visit us on Stand B28

Loading

Diamond Partner

Platinum Partner

Emerald Partner

Gold Partner

Silver Partner


 

Media Partner


 

Programme Sponsors


 

Practical Sponsors